Keratin 19 regulates cell cycle pathway and sensitivity of breast cancer cells to CDK inhibitors.

Sharma P, Alsharif S, Bursch K, Parvathaneni S, Anastasakis DG, Chahine J, Fallatah A, Nicolas K, Sharma S, Hafner M, Kallakury B, Chung BM. Keratin 19 regulates cell cycle pathway and sensitivity of breast cancer cells to CDK inhibitors. Sci Rep. 2019 10 10; 9(1):14650.

View in: PubMed

subject areas

Antineoplastic Agents
Breast
Breast Neoplasms
Cell Cycle
Cyclin D3
Cyclin-Dependent Kinases
Drug Resistance, Neoplasm
Female
Gene Knockout Techniques
Humans
Keratin-19
Protein Kinase Inhibitors

authors with profiles

Sudha Sharma

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support